Acceptance and Commitment Therapy for Stem Cell Transplant
(ACTivate Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is a phase 2, multicenter, randomized controlled trial to test the application of Acceptance and Commitment Therapy (ACT) in HCT patients.
ACT is an evidence-based cognitive behavioral therapy intervention that emphasizes psychological flexibility and behaviors, helping transplant patients focus on actions that may help maintain adequate physical activity despite physical and emotional discomfort.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Acceptance and Commitment Therapy (ACT) sessions to improve psychological flexibility and physical activity
Follow-up
Participants are monitored for changes in physical function and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- ACT
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants in the ACTivate arm will attend ACTivate sessions.
Participants in the education control arm will not attend ACTivate sessions.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Anthony Sung, MD
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.